NON-ALCOHOLIC STEATOHEPATITIS
Clinical trials for NON-ALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes drug could be key to halting silent liver damage
Disease control OngoingThis large, late-stage study is testing whether a weekly injection of semaglutide can help control and improve a serious fatty liver disease called NASH. About 1,200 adults with NASH will receive either the real medication or a placebo for up to five years to see if it can resolv…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New scanner could spot fatty liver without MRI
Diagnosis TerminatedThis study aimed to test a new type of ultrasound device for detecting and measuring fat in the liver. Researchers planned to compare the device's accuracy to the current standard method, an MRI scan. The trial was withdrawn before any participants were enrolled.
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC